Non-invasive prenatal testing market accounted for over US$ 1.5 Bn in 2019. It is anticipated to grow at a CAGR of approximately 16.2% from 2019 to 2030.
The rising prevalence of genetic disorders owing to increasing maternal age is promoting applications of Non-Invasive Prenatal Testing (NIPT) for early detection in fetal stages. For instance, the risk of fetus having Down syndrome is about 1 in 1,250 for women who conceive at the age of 25. The risk increases to about 1 in 100 for women who conceive at the age of 40. Moreover, there are several agreements signed for the promotion of NIPT. For instance, in February 2018, Harvard Pilgrim signed a value-based contract with Illumina, Inc. to enable wider patient access to the next generation of noninvasive testing for the detection of prenatal genetic abnormalities. However, the complexities associated with Non-Invasive Prenatal Testing (NIPT) require trained professionals, which pose serious concern for growth of the market.
Major Key Players of the Non-Invasive Prenatal Testing (NIPT) Market are:
Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, QIAGEN, BGI, Agilent Technologies, Inc., Natera, Inc., YOURGENE HEALTH, CENTOGENE N.V., and PerkinElmer Inc., among others.
Get sample copy of “Non-Invasive Prenatal Testing (NIPT) Market” at: https://www.marketindustryreports.com/pdf/269
Non-Invasive Prenatal Testing involves replacing invasive testing methods, which pose serious risks to developing fetuses. Non-Invasive Prenatal Testing (NIPT) is an emerging technology, which can be performed within 9 weeks of pregnancy and involves no risk of miscarriage. In addition, it offers clinical benefits over existing prenatal screening tests, such as maternal serum screening (MSS), by detecting the presence of trisomy 21 (Down syndrome, DS) with high sensitivity (99.9%) and specificity (98%). Moreover, there are several campaigns and programs conducted to spread awareness regarding Non-Invasive Prenatal Testing (NIPT) for the early detection of genetic abnormalities. This, in turn, contributes to growth of the Non-Invasive Prenatal Testing market.
The Non-Invasive Prenatal Testing (NIPT) Market is segmented on the basis of Product Types, Method, Application and region.
Major Product Types of Non-Invasive Prenatal Testing (NIPT) Market covered are:
- Consumables
- Instruments
- Services
Major Methods of Non-Invasive Prenatal Testing (NIPT) Market covered are:
- Biochemical Screening Tests
- Ultrasound Detection
- Cell-Free DNA in Maternal Plasma Tests
- Fetal Cells in Maternal Blood Tests
Major Applications of Non-Invasive Prenatal Testing (NIPT) Market covered is:
- Trisomy
- Microdeletion Syndrome
Increasing developmental strategies by key players, such as agreements, collaborations, and new product launches, in different regions are promoting market growth. For instance, in April 2019, Thermo Fisher Scientific and NX Prenatal Inc. entered into a collaboration for the development of clinical mass spectrometry-based proteomics assays to monitor maternal & fetal health during pregnancy and provide noninvasive risk assessments of pregnancy outcomes. Similarly, some key players are focusing on providing access to comprehensive NIPT solutions across various regions. For instance, in June 2019, BGI Genomics and Eluthia launched BGI’s leading non-invasive prenatal test, NIFTY in Germany. The test screens for trisomies 21, 18, 13 with a sensitivity rate of over 99%. In addition, it also has additional screening options for 93 other trisomies, sex chromosomal aneuploidies, and deletion/duplication syndromes.
Research objectives:-
– To study and analyze the global Non-Invasive Prenatal Testing (NIPT) consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Non-Invasive Prenatal Testing (NIPT) Market by identifying its various sub-segments.
– Focuses on the key global Non-Invasive Prenatal Testing (NIPT) manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Non-Invasive Prenatal Testing (NIPT) with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Table of Content
- INTRODUCTION
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
- Overview
- Drivers
- Barriers/Challenges
- Opportunities
- GLOBAL NON-INVASIVE PRENATAL TESTING MARKET – ANALYSIS & FORECAST, BY PRODUCT
- Consumables
- Assay Kits & Reagents
- Disposables
- Instruments
- Next-Generation Sequencing Systems
- Ultrasound Devices
- Polymerase Chain Reaction Instruments
- Microarrays
- Other Instruments
- Services
- Consumables
- GLOBAL NON-INVASIVE PRENATAL TESTING MARKET – ANALYSIS & FORECAST, BY METHOD
- Biochemical Screening Tests
- Ultrasound Detection
- Cell-Free DNA in Maternal Plasma Tests
- Fetal Cells in Maternal Blood Tests
- GLOBAL NON-INVASIVE PRENATAL TESTING MARKET – ANALYSIS & FORECAST, BY APPLICATION
- Trisomy
- Microdeletion Syndrome
- Other Applications
- GLOBAL NON-INVASIVE PRENATAL TESTING MARKET – ANALYSIS & FORECAST, BY END USER
- Diagnostic Laboratories
- Hospitals
- GLOBAL NON-INVASIVE PRENATAL TESTING MARKET – ANALYSIS & FORECAST, BY REGION
- North America Non-Invasive Prenatal Testing (NIPT) Market
- Europe Non-Invasive Prenatal Testing (NIPT) Market
- Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market
- Rest of the World (ROW) Non-Invasive Prenatal Testing (NIPT) Market
- COMPETITIVE LANDSCAPE
- Key Players & Their Competitive Positioning (2018)
- Key Strategies Assessment
- New Product Launches
- Merger & Acquisitions
- Agreements, Collaborations, & Partnerships
- Expansions
- Other Strategies
- COMPANY PROFILES(Business Overview, Products Offered, Financial Performance, Recent Developments)*
- Illumina, Inc.
- Thermo Fisher Scientific Inc
- F. Hoffmann-La Roche Ltd
- QIAGEN
- BGI
- Agilent Technologies, Inc.
- Natera, Inc.
- YOURGENE HEALTH
- CENTOGENE N.V.
- PerkinElmer Inc.
*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain
Have any query? Inquiry about report at: https://www.marketindustryreports.com/inquiry/269
About Us
Market Industry Reports is a global leader in market measurement and advisory services. It is a 100% subsidiary of ExlTech. The firm has always been at the forefront of innovations to address worldwide industry trends and opportunities. We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates consumer study in more than 100 countries, providing a tactical approach to drive sustained business growth. We continue to pioneer state-of-the-art approach in research & analysis that will help you to overcome complexities and stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence, we unfold contingencies for our clients in the evolving world of technology, mega-trends, and industry convergence. We inspire our clients to empower and shape their businesses and to build world-class products.
Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com
